title: Current problems in cardiac transplantation.
abstract: Since our initial orthotopic heart transplant (OHT) in 1968, the first in Europe, 1130 patients with ages ranging from 1 month to 66 years have been referred to us. The cause of irreversible myocardial damage was idiopathic cardiomyopathy in 74%, ischemic heart disease in 19% and left ventricular failure after valvular replacement in 7%. A total of 540 transplantations, 463 orthotopic, 40 heterotopic and 37 heart-lungs were carried out. Features of the early post-operative course include temporary (first week) cardiac instability treated by isoproterenol. Later complications included rejection (95%) and side-effects of immunosuppressive therapy; infection (83%), osteoporosis, malignancy, graft atherosclerosis (2%). Cyclosporine (Cy) was responsible for diastolic hypertension, renal dysfunction, hirsutism, hyperplasia of the gingiva, hepatic dysfunction, and seizures. The survival rate of the Cy-treated patients was 68% at 7 years. All survivors have virtually normal social and professional lives, included the longest survivor 14 years after the operation. Recently in 34 patients in acute irreversible cardiac failure and who cannot have a transplant in time, we implant a total artificial heart (TAH) type JARVIK 7 during a period from 1-150 days. There has been no mechanical failure, hemolysis or thrombo-embolism and only one right ventricular device malposition; 20 patients died before transplantation, 13 were successfully transplanted, 1 is still on the artificial heart. Heart transplantation, and TAH used as a bridge to transplantation are now an accepted therapeutic means for irreversibly cardiac failure in selected patients.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Cardiovascular Surgery, Hôpital de la Pitié, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Cabrol
authors.forename: I
authors.initials: I
authors.lastname: Gandjbakhch
authors.forename: A
authors.initials: A
authors.lastname: Pavie
authors.forename: V
authors.initials: V
authors.lastname: Bors
authors.forename: G
authors.initials: G
authors.lastname: Rabago
authors.forename: A
authors.initials: A
authors.lastname: Miralles
authors.forename: E
authors.initials: E
authors.lastname: Solis
authors.forename: A
authors.initials: A
authors.lastname: Cabrol
authors.forename: P
authors.initials: P
authors.lastname: Leger
authors.forename: J P
authors.initials: JP
authors.lastname: Levasseur
mesh_terms: D016027:Heart Transplantation; D006801:Humans; D014184:Transplantation, Homologous